Zika Virus: Medical Countermeasure Development Challenges - Test2 - elhamkhani - TriplyDB

Zika Virus: Medical Countermeasure Development Challenges

Zika Virus: Medical Countermeasure Development Challenges

http://www.wikidata.org/entity/Q24261184

about

Zika Virus Infection: Current Concerns and Perspectives Research and development of Zika virus vaccines.Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome Zika virus: An emergent neuropathological agent Response: Commentary: Zika Virus: the Latest Newcomer OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug Discovery Neurological manifestations of Zika virus infection Characterization of a 2016 Clinical Isolate of Zika Virus in Non-human Primates Zika Virus (ZIKV)Zika Virus May Affect the Universal Two-Child Policy: A New Challenge for China Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice Equine Immunoglobulin and Equine Neutralizing F(ab')₂ Protect Mice from West Nile Virus Infection Possible Roles of New Mutations Shared by Asian and American Zika Viruses Dynamic Forecasting of Zika Epidemics Using Google Trends Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery The spectrum of neuropathological changes associated with congenital Zika virus infection Scientometric analysis of research on Zika virus Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis.Prevention and Control Strategies to Counter ZIKA Epidemic.Risk of bias and confounding of observational studies of Zika virus infection: A scoping review of research protocols MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.Potential for treatment and a Zika virus vaccine.Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases.Ghost probiotics with a combined regimen: a novel therapeutic approach against the Zika virus, an emerging world threat.The contribution of Glycobiology to the Zika outbreak in the Americas.Recent Perspectives on Genome, Transmission, Clinical Manifestation, Diagnosis, Therapeutic Strategies, Vaccine Developments, and Challenges of Zika Virus Research Ethical, legal and societal considerations on Zika virus epidemics complications in scaling-up prevention and control strategies Anxiety, depression, and quality of life in mothers of newborns with microcephaly and presumed congenital Zika virus infection: a follow-up study during the first year after birth.Higher Cytopathic Effects of a Zika Virus Brazilian Isolate from Bahia Compared to a Canadian-Imported Thai Strain.[Zika virus infection and the nervous system].Characterization of stress degradation products of amodiaquine dihydrochloride by liquid chromatography with high-resolution mass spectrometry and prediction of their properties by using ADMET Predictor™.Prevention and Control Strategies to Counter Zika Virus, a Special Focus on Intervention Approaches against Vector Mosquitoes-Current Updates.Clinical and Laboratory Profile of Zika and Dengue Infected Patients: Lessons Learned From the Co-circulation of Dengue, Zika and Chikungunya in Brazil.Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.Structural Transition and Antibody Binding of EBOV GP and ZIKV E Proteins from Pre-Fusion to Fusion-Initiation State.Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869.Point-of-care microfluidic devices for pathogen detection

P2860

Q24289634-3FD4433C-14EA-4F7F-A771-49A7975635A2 Q26252115-51F9B22C-9F21-40F4-A22A-2ADA017E8DD6 Q26700454-F52BAD80-F643-489C-ABFE-A1ADE886C99F Q27010749-10403E59-00EF-4EC5-B426-A6050B918278 Q27468755-FDCE20B8-F842-49F3-A414-629FC3091683 Q27485305-EB5A34BD-528E-4707-B232-C080CAA93DCD Q27927995-CE069110-7431-43B6-8259-C68EEF0304BF Q27928064-D817141D-64EE-4D7A-9A10-ED90941EEABC Q28119390-EEFB7DA0-E6EE-4775-AA49-D148471CA60E Q28119642-9ED4D17D-E38C-466E-A8E6-272CFCE5D6D0 Q28223043-8F672569-B9AA-4B71-94E3-D7C5EC1687B7 Q28353948-80386C16-57D5-4175-8DD8-55053491DA1E Q28595165-A1ED272D-0764-4883-84CE-F1FE7BDEF57B Q28595386-46F1CD3D-60E7-4B90-8034-70633E590D4E Q28733552-67FCF5C9-82D1-45A0-9F08-62A024F0F2C6 Q28804225-3DBC5C16-A6F8-42E8-BA95-E0E3656797D7 Q28817653-EBA08EB5-7F82-42BE-AE0B-6F6786B0C710 Q29364973-8A7398C2-CB32-475B-A4B8-C9EB34FF6387 Q30145656-639F3346-D6DF-49CF-9252-389CD603C181 Q30235062-DADB57EE-659F-4287-83FE-F364B1685D5C Q30235275-A13C195C-E0BE-4D38-AABA-F0817ED5C8C2 Q33883729-A34B53DF-9937-454B-B514-2B8B7FBE318B Q37174399-B0B3F47F-8B9B-4162-B4BF-E6F3DF5F6D4A Q38158967-9C7C2243-7DE9-4986-8759-30BBD5A3035C Q39025905-42D6DCCC-6F8E-4FDB-8916-EB09A0A01892 Q39203410-DCF90F1E-1D00-41D3-BC0E-09A945002805 Q40037758-3755ACC2-E733-4486-9205-9F7514A3C226 Q40058280-1533B002-FF10-4C40-B925-1C8B48EB629D Q41673108-A71A1191-F518-4393-9BED-F0187CBADD5C Q42350952-64D36BF1-88EA-442A-867B-D9C62405158F Q43037886-D8655A90-A5FD-4FE6-B551-5CCD915CFA92 Q47547869-112D8985-A0E1-4447-BF4E-CD84A7D2FAA9 Q47558002-952008B6-81B7-44DF-86C4-822FA0357DBD Q47850594-140C217D-5BD1-4F94-B494-999578F8C516 Q50277220-19D28A44-4538-4B09-BA23-3E27871CBFDF Q51335990-E9CC6449-7402-4E60-80F4-47C66903EE3D Q53693795-F9D14459-D074-4586-8205-E1DCF106520D Q54214972-2B87CC44-27D6-41B3-881A-29949329BAD9 Q54225573-528D5C3B-48E4-4967-842D-F3DA5A76C5A0 Q57461881-0831BAF2-8663-4E3D-AE7B-AF66ABDC1CC8

P2860

Zika Virus: Medical Countermeasure Development Challenges

http://www.wikidata.org/entity/Q24261184

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Zika Virus: Medical Countermeasure Development Challenges

@ast

Zika Virus: Medical Countermeasure Development Challenges

@en

Zika Virus: Medical Countermeasure Development Challenges

@en-gb

Zika Virus: Medical Countermeasure Development Challenges

@nl

type

label

Zika Virus: Medical Countermeasure Development Challenges

@ast

Zika Virus: Medical Countermeasure Development Challenges

@en

Zika Virus: Medical Countermeasure Development Challenges

@en-gb

Zika Virus: Medical Countermeasure Development Challenges

@nl

prefLabel

Zika Virus: Medical Countermeasure Development Challenges

@ast

Zika Virus: Medical Countermeasure Development Challenges

@en

Zika Virus: Medical Countermeasure Development Challenges

@en-gb

Zika Virus: Medical Countermeasure Development Challenges

@nl

P1433

Q24261184-F7F01FBD-C721-4DA0-985E-B41F928E8E97

P1476

Q24261184-025FC833-B846-4900-A90D-CA3F81DED9AD

P2093

Q24261184-22D88B89-EFA2-49D3-A741-112182F265DD

Q24261184-5B099EEE-728F-4002-8033-A988B1758A7D

Q24261184-7FE9B006-D756-447B-92A6-19A8DE5B4390

Q24261184-90CC3A14-DF09-41C5-AD16-F5CCFDC655F1

Q24261184-98911B54-9B86-4072-B1D5-D59D0AD671A1

Q24261184-A2082442-E538-4B48-A6A2-5CCBE4AF5E4B

Q24261184-A91C2685-04C9-4D80-B085-D6E1FDF3210A

Q24261184-B43D7E59-D188-40D4-BBDF-1F14EF543443

Q24261184-D885CFF0-B97A-4A56-9671-24934B45118C

P275

Q24261184-5FA34775-300D-4047-BE67-2B8F59CB2C06

Q24261184-B546E0D8-D456-4623-B16F-4D6B3E01AB65

P2860

Q24261184-00893409-93C8-4109-BFFD-80F5EF987300

Q24261184-042401E1-9BF8-49A1-8931-7DFF4BA223BA

Q24261184-0850A698-233C-42FB-83B1-2B660322DB9B

Q24261184-08D44A0C-0DDB-41ED-A27F-86F08034DF54

Q24261184-0B0390C5-D3CD-4AA4-ABF9-A190781401EC

Q24261184-0C1D6060-5BA5-42A3-8C7E-8ADD501C4CDE

Q24261184-0DB4DA3D-1FDD-4D32-8EA1-1554E69523EA

Q24261184-11E45E2D-E33E-49EC-8B54-38F4B8AE7720

Q24261184-138DAC9C-EC15-4582-8D6E-90A30D42AF82

Q24261184-1AE6925A-2B6D-4BDF-848C-16B540C253E7

P304

Q24261184-1E320566-551F-4F3B-A907-040ECF1E5D06

P31

Q24261184-166AB47C-C77C-4D18-85C0-88303451B98F

Q24261184-85BFD6C3-92D8-44F6-8065-61C3C7242574

P3181

Q24261184-F32F6268-C3B2-47E7-8867-91BD7C7022CB

P356

Q24261184-62C5E694-EB93-4128-A75A-5429C208E865

P407

Q24261184-5FE30A59-D9D6-467C-9FD2-0EE2B47F122C

P433

Q24261184-ED463FE4-0011-4D10-9CA9-E3867FA94189

P478

Q24261184-FB5DA795-75EB-4E26-BA27-307EEE559BB7

P50

Q24261184-1AD30E8F-BA88-47AC-9C41-723E10CCFAA4

Q24261184-D449DADB-A4AE-4190-9149-674C9A7E35D7

Q24261184-b5f73de4-43e8-1d8f-7e8a-52f8546ee3ec

Q24261184-d04c6519-4702-bc91-08e8-e9664e7a291d

P5008

Q24261184-0A11AAFC-FB02-4230-969F-5688639CF542

Q24261184-BA60C2C7-D9CC-4201-96C7-F6011BAF6553

P577

Q24261184-06AAD960-7B41-41C3-BA29-70C8B6032369

Q24261184-8A7526AD-F485-4FCF-A353-4707E337E359

P5875

Q24261184-2B5548EB-F6B3-498D-A672-D665017872AA

P698

Q24261184-7AD1D407-5FBC-4FFB-95E1-C11BAF3FADB1

P921

Q24261184-4DF02C13-236E-4A4D-9124-5651A4C6EB72

Q24261184-6009004F-9D61-4E75-BA5D-839B05EF03D5

P932

Q24261184-33391E1B-3FC0-4E98-B951-4374DEB585BB

P3181

P356

JOURNAL.PNTD.0004530

P1433

PLOS Neglected Tropical Diseases

P1476

Zika Virus: Medical Countermeasure Development Challenges

@en

P2093

Daniel Janies

http://www.w3.org/2001/XMLSchema#string

Ivan Ruzic

http://www.w3.org/2001/XMLSchema#string

James Talton

http://www.w3.org/2001/XMLSchema#string

Jane Homan

http://www.w3.org/2001/XMLSchema#string

Jill Glasspool-Malone

http://www.w3.org/2001/XMLSchema#string

Michael V Callahan

http://www.w3.org/2001/XMLSchema#string

Rebecca Zimler

http://www.w3.org/2001/XMLSchema#string

Robert W Malone

http://www.w3.org/2001/XMLSchema#string

Ronald R Cobb

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

Creative Commons Attribution 4.0 International

P2860

A single mutation in chikungunya virus affects vector specificity and epidemic potential

Zika virus. I. Isolations and serological specificity

Zika virus outside Africa

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007

Molecular evolution of Zika virus during its emergence in the 20(th) century

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis

IVIG treatment and prognosis in Guillain-Barré syndrome

Autophagy and viral diseases transmitted by Aedes aegypti and Aedes albopictus

Zika and microcephaly: causation, correlation, or coincidence?

P304

e0004530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2707642

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PNTD.0004530

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Lambodhar Damodaran

Adriano de Bernardi Schneider

Julie Smith-Gagen

James M. Wilson

P5008

WikiProject Zika Corpus

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295086702

http://www.w3.org/2001/XMLSchema#string

P698

26934531

http://www.w3.org/2001/XMLSchema#string

P921

P932

4774925

http://www.w3.org/2001/XMLSchema#string